About Arrow® from Teleflex

We are a global leader focused on reducing vascular-related complications through world-class solutions designed to equally benefit clinicians and patients. Our goal is to provide intuitive products and consultative programs that improve procedural efficiencies, patient outcomes, and healthcare economic value to advance care in Vascular Access.

See our interactive timeline »

2019 Events

September 29 - October 2, 2019
ENA 2019
Austin, TX
October 4-7, 2019
AVA 2019 Annual Scientific Meeting
Las Vegas, NV
October 19-23, 2019
Anesthesiology 2019
Orlando, FL
October 27-30, 2019
ACEP 2019
Denver, CO

Customer Support - United States

For information on the Arrow® Brand of products call:

866-246-6990 (toll free)

Vascular After-Hours Clinical / Emergency Customer Support Line

7PM – 8AM EST / 7 days 866-295-5857 USA & CANADA

Rx only Contraindication: The Arrowg+ard Blue Plus® CVC is contraindicated for patients with known hypersensitivity to chlorhexidine and silver sulfadiazine and/or sulfa drugs. Contraindication: Clinical assessment of the patient must be completed to ensure no contraindications exist. The Arrowg+ard Blue Advance PICC is contraindicated in the following areas: • Patients with known hypersensitivity to chlorhexidine • In presence of device related infections • In presence of previous or current thrombosis in the intended vessel or along the catheterized vessel pathway. No correlation between in vitro/in vivo testing methods and clinical outcomes have currently been ascertained. Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Advance, Arrowg+ard Blue Plus, and Endurance are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. All other trademarks are trademarks of their respective owners. MC-005648